Royalty Pharma plc (RPRX)

Royalty Pharma Revenue

Royalty Pharma had revenue of $2.24B in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $567.98M. In the year 2023, Royalty Pharma had annual revenue of $2.35B with 5.24% growth.

• Revenue (ttm): $2.24B
• Revenue Growth: -5.11%
• P/S Ratio: 5.68
• Revenue / Employee: $25,152,371
• Employees: 89
• Market Cap: 12.72B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.35B	117.34M	5.24%
Dec 31, 2022	2.24B	-52.25M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%
Dec 31, 2019	1.81B	19.36M	1.08%
Dec 31, 2018	1.79B	196.96M	12.33%
Dec 31, 2017	1.60B	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.